These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 32913111)

  • 1. Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer.
    Bao B; Teslow EA; Mitrea C; Boerner JL; Dyson G; Bollig-Fischer A
    Mol Cancer Res; 2020 Dec; 18(12):1803-1814. PubMed ID: 32913111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells.
    Teslow EA; Mitrea C; Bao B; Mohammad RM; Polin LA; Dyson G; Purrington KS; Bollig-Fischer A
    Mol Oncol; 2019 Apr; 13(4):894-908. PubMed ID: 30636104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Co-Deregulation of EZH2/TET1 is a Senescence-Countering, Actionable Vulnerability in Triple-Negative Breast Cancer.
    Yu Y; Qi J; Xiong J; Jiang L; Cui D; He J; Chen P; Li L; Wu C; Ma T; Shao S; Wang J; Yu D; Zhou B; Huang D; Schmitt CA; Tao R
    Theranostics; 2019; 9(3):761-777. PubMed ID: 30809307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TET1 promotes 5hmC-dependent stemness, and inhibits a 5hmC-independent epithelial-mesenchymal transition, in cervical precancerous lesions.
    Su PH; Hsu YW; Huang RL; Chen LY; Chao TK; Liao CC; Chen CW; Wu TI; Mao SP; Balch C; Lai HC
    Cancer Lett; 2019 May; 450():53-62. PubMed ID: 30771438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of 5-hydroxymethylcytosine is an early event in pancreatic tumorigenesis.
    Fujikura K; Alruwaii ZI; Haffner MC; Trujillo MA; Roberts NJ; Hong SM; Macgregor-Das A; Goggins MG; Roy S; Meeker AK; Ding D; Wright M; He J; Hruban RH; Wood LD
    J Pathol; 2021 Jul; 254(3):279-288. PubMed ID: 33870509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation.
    Benešová M; Trejbalová K; Kučerová D; Vernerová Z; Hron T; Szabó A; Amouroux R; Klézl P; Hajkova P; Hejnar J
    Mol Carcinog; 2017 Aug; 56(8):1837-1850. PubMed ID: 28218476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic ethanol-mediated hepatocyte apoptosis links to decreased TET1 and 5-hydroxymethylcytosine formation.
    Ji C; Nagaoka K; Zou J; Casulli S; Lu S; Cao KY; Zhang H; Iwagami Y; Carlson RI; Brooks K; Lawrence J; Mueller W; Wands JR; Huang CK
    FASEB J; 2019 Feb; 33(2):1824-1835. PubMed ID: 30188753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer.
    Ayodeji SA; Bao B; Teslow EA; Polin LA; Dyson G; Bollig-Fischer A; Fehl C
    Cancer Cell Int; 2023 May; 23(1):102. PubMed ID: 37231419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ten-eleven translocation protein 1 modulates medulloblastoma progression.
    Kim H; Kang Y; Li Y; Chen L; Lin L; Johnson ND; Zhu D; Robinson MH; McSwain L; Barwick BG; Yuan X; Liao X; Zhao J; Zhang Z; Shu Q; Chen J; Allen EG; Kenney AM; Castellino RC; Van Meir EG; Conneely KN; Vertino PM; Jin P; Li J
    Genome Biol; 2021 Apr; 22(1):125. PubMed ID: 33926529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer.
    Good CR; Panjarian S; Kelly AD; Madzo J; Patel B; Jelinek J; Issa JJ
    Cancer Res; 2018 Aug; 78(15):4126-4137. PubMed ID: 29891505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.
    Cakouros D; Hemming S; Gronthos K; Liu R; Zannettino A; Shi S; Gronthos S
    Epigenetics Chromatin; 2019 Jan; 12(1):3. PubMed ID: 30606231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
    Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
    Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
    Wang P; Yan Y; Yu W; Zhang H
    Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating 5hmC and gene expression data to infer regulatory mechanisms.
    Mitrea C; Wijesinghe P; Dyson G; Kruger A; Ruden DM; Draghici S; Bollig-Fischer A
    Bioinformatics; 2018 May; 34(9):1441-1447. PubMed ID: 29220513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC.
    Xu Q; Wang K; Wang L; Zhu Y; Zhou G; Xie D; Yang Q
    PLoS One; 2016; 11(8):e0161261. PubMed ID: 27548812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated
    Ramsawhook A; Lewis L; Coyle B; Ruzov A
    Clin Epigenetics; 2017; 9():18. PubMed ID: 28228863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear exclusion of TET1 is associated with loss of 5-hydroxymethylcytosine in IDH1 wild-type gliomas.
    Müller T; Gessi M; Waha A; Isselstein LJ; Luxen D; Freihoff D; Freihoff J; Becker A; Simon M; Hammes J; Denkhaus D; zur Mühlen A; Pietsch T; Waha A
    Am J Pathol; 2012 Aug; 181(2):675-83. PubMed ID: 22688054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells.
    Neri F; Incarnato D; Krepelova A; Rapelli S; Pagnani A; Zecchina R; Parlato C; Oliviero S
    Genome Biol; 2013 Aug; 14(8):R91. PubMed ID: 23987249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TET1-mediated epigenetic modulation in Alzheimer's disease.
    Armstrong MJ; Jin Y; Vattathil SM; Huang Y; Schroeder JP; Bennet DA; Qin ZS; Wingo TS; Jin P
    Neurobiol Dis; 2023 Sep; 185():106257. PubMed ID: 37562656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.